XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 28,000 $ 76,101,000 $ (64,523,000) $ 11,606,000
Balance, shares at Dec. 31, 2018 28,392,853      
Common Stock issued for legal fees 126,000 126,000
Common Stock issued for legal fees, shares 50,000      
Issuance of Common Stock 186,000 186,000
Issuance of Common Stock, shares 182,778      
Issuance of Common Stock for Note Conversion $ 1,000 638,000 639,000
Issuance of Common Stock for Note Conversion, shares 424,805      
Common Stock issued for directors fees 244,000 244,000
Common Stock issued for directors fees, shares 257,602      
Stock Compensation Expense 378,000 378,000
Other Adjustments - Shares Issued
Other Adjustments - Shares Issued, shares 170,300      
Other Adjustments - FV Allocation (126,000) (126,000)
Share Issuance Costs (113,000) (113,000)
Other Adjustments - Rounding (2,000) (2,000)
Net Income (Loss) (2,732,000) (2,732,000)
Balance at Dec. 31, 2019 $ 29,000 77,434,000 (67,257,000) 10,206,000
Balance, shares at Dec. 31, 2019 29,478,338      
Issuance of Common Stock $ 1,000 983,000 984,000
Issuance of Common Stock, shares 419,597      
Common Stock issued for directors fees 211,000 211,000
Common Stock issued for directors fees, shares 178,405      
Costs related to issuance of stock (145,000) (145,000)
Common Stock Issued for Convertible Notes $ 2,000 2,587,000 2,589,000
Common Stock Issued for Convertible Notes, shares 1,830,631      
Stock Compensation Expense 308,000 308,000
Adjustments for other note conversions (140,000) (140,000)
Net Income (Loss) 1,096,000 1,096,000
Balance at Dec. 31, 2020 $ 32,000 $ 81,238,000 $ (66,161,000) $ 15,109,000
Balance, shares at Dec. 31, 2020 31,906,971